| 中药大品种科技竞争力报告（2019版）概要 |
| 投稿时间：2020-01-07 点此下载全文
|
| 引用本文：李耿,郭宇博,李文姗,李森,周瑞,王欢欢,乔三洋,段笑娇,李振坤,张秀梅,杨洪军.中药大品种科技竞争力报告（2019版）概要[J].中国现代中药,2020,22(1):1-20 |
| DOI： |
| 摘要点击次数: 1428 |
| 全文下载次数: 456 |
|
|
| 基金项目:中国科协项目（2018-64）；国家中医药管理局项目（GZY-KJS-2018-016-09，GZY-FJS-2018-612）；国家重点研发计划（2018YFB1403500） |
|
| 中文摘要:当前，由于中药产品优胜劣汰的竞争逻辑不清晰，导致中药竞争力提升缓慢，产业发展陷入困境。以临床价值、科学价值为核心的科技创新驱动，成为推动中药产业高质量发展的核心关键。通过中药产品的差异化评价，可以有效强化中药产品竞争。科技竞争力集中反映了中药产品的临床价值、科学价值，更折射出企业对产品的态度。通过对中药产品科技竞争力进行评价，可以较为全面地比较产品的内在价值。在持续深入研究中药产品科技竞争力评价模型，连续3年发布《中药大品种科技竞争力报告》（以下简称《报告》）的基础上，工作组编制《报告》（2019版）。本文为《报告》（2019版）概要，详细阐释了中药大品种科技竞争力评价模型的指标权重和算法体系，介绍了2019年评价工作情况和评价结果，基于评价结果分析了各地区、各治疗领域、各类型中成药产品相关科技创新的状况。可以看出，《报告》中优势中药产品与国家基本药物、医保目录品种遴选以及中药产业科技大奖都存在较高的相关性，基于《报告》（2019版）的现实影响与积极的产业引导作用，未来《报告》不仅可为“筛选疗效独特中药品种”等科学决策提供数据支撑，也可为中药产品淘汰、重点监控品种等“汰劣”型决策提供参考依据；还可用于中药企业产品学术推广，价值与风险研判，中药企业战略规划、并购、投融资，以及项目、奖励申报。 |
| 中文关键词:中药大品种 科技竞争力 产品评价 大数据 评价模型 指标权重 科技因子 |
| |
| Summary of Competitiveness Report on Science and Technology of Big Brand Traditional Chinese Medicine （2019 Edition） |
|
|
| Abstract:At present，due to the unclear competitive logic of the survival of the fittest of traditional Chinese medicine products，the competitiveness of traditional Chinese medicine is promoted slowly，and the industry development is in a dilemma.Scientific and technological innovation driven by clinical value and scientific value has become the key to break out of the dilemma and promote the high-quality development of traditional Chinese medicine industry.Through the differential evaluation of traditional Chinese medicine products，it can effectively strengthen the competition of traditional Chinese medicine products.Science and technology have reflected the clinical value and scientific value of traditional Chinese medicine products，and also the attitude of enterprises towards products.Through the evaluation of the scientific and technological competitiveness of traditional Chinese medicine products，we can compare the internal value of the products comprehensively.Based on the continuous in-depth study of the evaluation model of scientific and technological competitiveness of traditional Chinese medicine products and the issuance of the report on scientific and technological competitiveness of large varieties of traditional Chinese medicine （hereinafter referred to as the report） for three consecutive years，the working group prepared the report （2019 version），which is summarized in this paper.In this paper，the index weight and algorithm system of the evaluation model of scientific and technological competitiveness of large varieties of traditional Chinese medicine are described in detail，the work in 2019 and the evaluation results are presented，and the basic situation of scientific and technological innovation of various regions，treatment fields and types of traditional Chinese medicine industry is analyzed systematically.The superior traditional Chinese medicine products in the report are highly related to the selection of national essential drugs，medical insurance catalog varieties and the science and technology award of traditional Chinese medicine industry.Based on the practical influence and positive industry guidance function of the report，it can not only provide data support for scientific decision-making such as ″screening Chinese medicine varieties with unique curative effect″，also provide data support for the elimination of traditional Chinese medicine products and key monitoring varieties in the future.It can also be used for academic promotion，value and risk assessment，strategic planning，M & A，investment and financing，project and reward declaration of traditional Chinese medicine enterprises. |
| keywords:big brand traditional Chinese medicine scientific and technological competitiveness scientific and technological evaluation big data evaluation model index weight scientific factor score. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
